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Abstract 
Primary spinal primitive neuroectodermal tumors (PNETs) are very rare conditions. Most 
of these tumors occur in children and young adults. A 63-year-old man with a primary 
spinal PNET in the conus medullaris from the L1 to L2 level is presented in this report. 
The optimal treatment of primary spinal PNETs is yet unknown. Surgical resection, 
radiation therapy, and chemotherapy have been advocated for the treatment of spinal 
PNET based on PNETs at other sites. However, the outcome is very poor. There are a few 
reports of cases with long-term survival and no recurrence. In these patients, en bloc 
resections were performed. 
 
Introduction 
Primitive neuroectodermal tumors (PNETs) are rare malignant neoplasms which 
occur predominantly in children and young adults. PNETs belong to the Ewing’s sarcoma 
family of tumors and are associated with the same reciprocal chromosomal translocation 
as the Ewing’s sarcoma. 
PNETs usually develop in the cerebellum; however, they can also arise from other sites 
of the central nervous system (CNS) such as the cerebral hemispheres, cortex, pineal 
gland and brain stem. Primary spinal PNETs are very rare conditions, and up to now, Case Rep Oncol 2011;4:267–274 
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only 38 cases have been reported in the literature [1–26]. In this article, we report a rare 
case of a primary PNET of the conus medullaris in an elderly patient. The clinical, 
radiological and histological findings are presented and the relevant literature is reviewed. 
Case Report 
A previously healthy 63-year-old man was admitted to hospital with a 3 months’ history of lower 
back pain projecting into the right leg. Spinal magnetic resonance imaging (MRI) demonstrated a disc 
hernia at the L2-L3 level and an intradural tumor from the L1 to L2 level (fig. 1a–c). After resection of 
the disc hernia, an intradural tumor resection was performed. The tumor was resected intralesionally 
because it was adhered to the spinal cord and nerve roots. Histopathological examination of the tumor 
specimen revealed a highly cellular, poorly differentiated neoplasm. The tumor was composed of small 
round cells with scanty cytoplasm and hyperchromatic nuclei. No well-defined Homer Wright and only 
a few ependymal rosettes were found (fig. 2a). Immunohistochemical staining for neuron-specific 
enolase (NSE) was strongly positive, as was staining for CD99 (MIC2) (fig. 2b). On the other hand, there 
was no evidence of significant epithelial differentiation. 
Two months after the operation, the patient complained of progressive paresthesia and weakness of 
the right leg and was referred to our hospital. Spinal MRI demonstrated an intraspinal tumor extending 
from the Th12 to L2 level. The tumor showed high intensity on both T1- (fig. 3a) and T2-weighted 
images (fig. 3b). The patient underwent chemotherapy with a protocol for Ewing’s sarcoma family of 
tumors, because the results of the histopathological examination of the tumor led us to reject the 
diagnoses of lymphoma and poorly differentiated carcinoma and confirmed the diagnosis of PNET (fig. 
4). Additionally, he received radiation therapy consisting of 16 Gy to the spinal cord and 14 Gy to the 
whole brain and spinal cord. After these treatments, his neurologic symptoms completely resolved and 
the tumor disappeared on MRI (fig. 5a–c). 
The patient continued low-dose chemotherapy with etoposide; however, 21 months after the 
operation, he again experienced paresthesia and weakness of the right leg because of recurrence of the 
tumor. He was then treated with a multidrug chemotherapy again, but his symptoms did not improve. 
He died due to progressive paresis 25 months after the operation. 
Discussion 
Primary spinal PNETs are rare lesions. The majority of spinal PNETs are the result of 
subarachnoidal spread of tumors in the neuraxis. In 1973, the term PNET was first 
introduced by Hart and Earle [27] to describe undifferentiated cerebral tumors. 
Reviewing this term, in 1983, Rorke [28] defined PNETs as ‘central nervous system 
tumors predominantly composed of undifferentiated neuroepithelial cells’. At the same 
time, they subclassified these tumors on the basis of their cellular differentiation. Finally, 
in 1993, the World Health Organization (WHO) classification grouped these tumors into 
the category of embryonal tumors composed of undifferentiated or less differentiated 
neuroepithelial cells which have the capacity of differentiation to astrocytes, ependymal 
cells, melanocytes or muscle cells [25]. 
Histopathologically, PNETs are undifferentiated, small, round-cell tumors with 
hyperchromatic nuclei and features of neural differentiation, which typically form Homer 
Wright rosettes. The amount and quality of rosette formation vary substantially; some 
tumors may only show abortive rosette formation. On immunohistochemical 
examination, the most useful antibody for the diagnosis of PNET is the monoclonal 
antibody CD99, directed against the cell surface protein MIC2 whose gene is located on 
the pseudoautosomal region of the X and Y chromosomes. PNETs often have the same Case Rep Oncol 2011;4:267–274 
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reciprocal chromosomal translocation, i.e. t(11;22)(q24;q12), which is the other key to the 
diagnosis of PNET [20]. 
PNETs involving the spinal cord are most commonly drop metastases from primary 
intracranial tumors, which disseminate via the cerebrospinal fluid. Therefore, primary 
intraspinal PNETs are extremely rare, and to our knowledge, only 38 cases have been 
reported in the literature so far (table 1) [1–26]. The age of the disease manifestation, 
including our case, ranged from 0 to 69 years, with an average age of 25.1 years. Our 
patient is the second oldest of all reported cases so far. In addition, there seems to be a 
male predominance for these tumors. 
The optimal treatment of primary spinal PNETs is unknown because the tumors are 
very rare. Surgical resection, radiotherapy, and chemotherapy have been advocated for 
the treatment of spinal PNET based on PNETs at other sites. However, there is no 
agreement on the radiotherapy schedule, irradiance, and region (spine, brain, or both of 
them), as well as on the use and regimen of chemotherapy for PNETs. Successful results 
were reported using combinations of vincristine, doxorubicin, cyclophosphamide, 
ifosfamide and etoposide in Ewing’s sarcoma. Despite multimodal treatment combining 
surgery, radiotherapy, and chemotherapy, the outcome is very poor. However, there are a 
few reports of cases with long-term survival and no recurrence. In these patients, en bloc 
resection was performed [20]. 
In conclusion, primary spinal PNETs are very rare tumors seldom affecting elderly 
patients. Therefore, their treatment is not established. In spite of surgery, radiation 
therapy, and chemotherapy, the outcome is very poor. It seems that the key for long-term 
survival is early detection and en bloc resection. 
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Table 1. Summary of patients with a primary spinal PNET 
Patient  
[ref.] 
Age  Sex  Site  Survival period  Recurrence and metastasis 
01 [1]  24 years  M  lumbar, cauda equina  10 months  lung 
02 [2]  6 months to  
10 years 
NA cervical  NA  NA 
03 [2]  6 months to  
10 years 
NA cervical  NA  NA 
04 [2]  6 months to  
10 years 
NA thoracic-lumbar  NA  NA 
05 [3]  24 years  M  lumbar, intradural, cauda equina  18 months  local recurrence 
06 [3]  56 years  M  lumbar, intradural, cauda equina  alive at 36 month  none 
07 [3]  39 years  M  lumbar, intradural, cauda equina  30 months  local recurrence 
08 [4]  26 years  M  cervical, intradural, extramedullary  10 days  spinal canal, diffuse bone 
09 [5]  26 years  F  lumbar-sacral, extradural  alive at 6 months  none 
10 [6]  26 years  M  thoracic-lumbar, intramedullary  36 months  between two frontal horns, 
roof 4th ventricle 
11 [6]  15 years  F  thoracic-lumbar, intra- and  
extramedullary 
18 months  local recurrence 
12 [7]  7 years  M  thoracic-sacral, intramedullary  20 months  local progression to cervical 
13 [8]  16 years  F  lumbar, intramedullary  29 months  brain 
14 [9]  47 years  M  lumbar-sacral, cauda equina, 
 intra- and extramedullary 
16 months  local progression 
15 [10]  3 months  F  thoracic-lumbar, intramedullary  15 days  brain 
16 [11]  22 years  F  thoracic-lumbar, intramedullary  alive at 15 months  local recurrence 
17 [12]  23 years  F  thoracic, intradural extramedullary  alive at 12 months  none 
18 [13]  32 years  M  sacral, cauda equina  29 months  local progression, brain 
19 [13]  17 years  M  lumbar, cauda equina  alive at 23 months  none 
20 [14]  52 years  M  lumbar-sacral, cauda equina  alive at 12 months  none 
21 [15]  5 years  M  thoracic, extradural  alive at 8 months  none 
22 [16]  69 years  M  cervical-thoracic, intra- and  
extramedullary 
3 months  none 
23 [17]  22 years  F  thoracic, extramedullary  alive at 9 months  local recurrence, brain 
24 [18]  49 years  F  lumbar, cauda equina  23 months  diffuse intraspinal  
progression 
25 [18]  29 years  F  thoracic, intramedullary  17 months multiple  intraspinal 
26 [19]  26 years  M  cervical, intrameningeal  3 months  local recurrence, diffuse 
intraspinal 
27 [20]  12 years  F  cervical-thoracic, extradural  32 months  local recurrence 
28 [20]  10 years  M  cervical-thoracic, extradural  22 months multiple  lung 
29 [20]  30 years  F  cervical, extramedullary  14 months  local recurrence 
30 [20]  14 years  M  lumbar, extramedullary  alive at 67 months  none 
31 [21]  31 years  F  lumbar-sacral, cauda equina  2 months  local recurrence, left  
frontoparietal 
32 [22]  3 years  M  cervical, intramedullary  several days  local progression to  
brainstem 
33 [23]  38 years  M  thoracic, intramedullary  18 months  brain, multiple spinal cord 
34 [24]  54 years  F  cervical, intramedullary  NA  none 
35 [25]  9 years  F  thoracic-lumbar, extramedullary  alive at 18 months  none 
36 [25]  8 years  M  cervical, extradural  alive at 8 months  local recurrence 
37 [25]  18 years  M  cervical, intramedullary  alive at 6 months  none 
38 [26]  17 years  M  thoracic, intramedullary  alive at 6 months  none 
NA = Not available. 
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Fig. 1. Spinal MRI showed a disc hernia at the L2-L3 level and a generally isointense intradural tumor 
with focal high-intensity T1-weighted images at the level of L1-L2 (a). On T2-weighted MRI, the tumor 
demonstrated high intensity with focal low intensity (b). The tumor is homogenously enhanced by 
gadolinium (c). 
 
 
 
Fig. 2. Histopathological examination of the tumor specimen revealed a highly cellular, poorly 
differentiated neoplasm. The tumor was composed of small round cells with scanty cytoplasm and 
hyperchromatic nuclei. No well-defined Homer Wright and only a few ependymal rosettes were found 
(a). Immunohistochemical staining for NSE was strongly positive (pictures not shown), as was staining 
for CD99 (MIC2) (b). 
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Fig. 3. Spinal MRI demonstrated an intraspinal tumor extending from the Th12 to L2 level. The tumor 
showed high intensity on T1-weighted image (a) as well as on T2-weighted image (b). 
 
 
 
Fig. 4. Protocol of chemotherapy. RT-1 = Local radiation 16 Gy; RT-2 = radiation to brain and spinal 
cord 14 Gy; VDC = vincristine (1.5 mg/m
2) + doxorubicin (30 mg/m
2) + cyclophosphamide (1,200 
mg/m
2); IE = ifosfamide (1.8 g/m
2) + etoposide (100 mg/m
2). 
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Fig. 5. MRI after chemotherapy and radiation. a T1-weighted image. b T2-weighted image.  
c T1-weighted image with gadolinium enhancement. 
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